Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Erbitux TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: cetuximab
Brand name
(ARTG)
: ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusionDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Erbitux is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer. In combination with infusional 5-fluorouracil/folinic acid plus irinotecan. In combination with irinotecan in patients who are refractory to first-line chemotherapy. In first-line in combination with FOLFOX. As a single agent in patients who have failed or are intolerant to oxaliplatin-based therapy and irinotecan-based therapy. (See CLINICAL TRIALS) Erbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck. In combination with radiation therapy for locally advanced disease. In combination with platinum-based chemotherapy for recurrent and/or metastatic disease.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, intravenous infusion
- Intravenous
- Clear to slightly opalescent, colourless to yellowish solution.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 20mL vial pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient cetuximab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
